Advanced search
Publication Cover
Pediatric Pathology & Molecular Medicine Volume 21, 2002 - Issue 3
Journal homepage
46
Views
23
CrossRef citations to date
0
Altmetric
Research Article

ACUTE PHASE SERUM AMYLOID A, CHOLESTEROL METABOLISM, AND CARDIOVASCULAR DISEASE

Robert Kisilevsky Queen's University, Department of Pathology, and The Syl and Molly Apps Research Center, Kingston General Hospital, Kingston, Ontario, Canada
&
Shui-Pang Tam Queen's University, Department of Pathology, and The Syl and Molly Apps Research Center, Kingston General Hospital, Kingston, Ontario, Canada
Pages 291-305 | Published online: 09 Jul 2009

  • Tape C, Tan R, Nesheim M, Kisilevsky R. Direct evidence for circulating apoSAA as the precursor of tissue AA amyloid deposits. Scand J Immumol 1998;28:317-324.
  • Liuzzo G, Biasucci LM, Gallimore JR, Grillo RL, Rebuzzi AG, Pepys MB, Maseri A. Prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina. N Engl J Med 1994;331:417-424.
  • Liuzzo G, Biasucci LM, Rebuzzi AG, Gallimore JR, Caligiuri G, Lanza GA, Quaranta G, Monaco C, Pepys MB, Maseri A. Plasma protein acute-phase response in unstable angina is not induced by ischemic injury. Circulation 1996;94:2373-2380.
  • Kisilevsky R, Subrahmanyan L. Serum amyloid A changes high density lipoprotein's cellular affinity: a clue to serum amyloid As principal function. Lab Invest 1992;66:778-785.
  • Banka CL, Yuan T, De Beer MC, Kindy M, Curtiss LK, de Beer FC. Serum amyloid A (SAA): Influence on HDL-mediated cellular cholesterol efflux. J Lipid Res 1995;36:1058-1065.
  • Lindhorst E, Young D, Bagshaw W, Hyland M, Kisilevsky R. Acute inflammation, acute phase serum amyloid A and cholesterol metabolism in the mouse. Biochim Biophys Acta 1997;1339:143-154.
  • Hayat S, Raynes JG. Acute phase serum amyloid a protein increases high density lipoprotein binding to human peripheral blood mononuclear cells and an endothelial cell line. Scand J Immunol 2000;51:141-146. SAA, Chotesterol, and Heart Disease 299
  • Uhlar CM, Burgess CJ, Sharp PM, Whitehead AS. Evolution of the serum amyloid A (SAA) protein superfamily. Genomics 1994;19:228-235.
  • Jensen LE, Hiney MP, Shields DC, Uhlar CM, Lindsay AJ, Whitehead AS. Acute phase proteins in salmonids - evolutionary analyses and acute phase response. J Immunol 1997;158:384-392.
  • Parmelee DC, Titani K, Ericsson LH, Eriksen N, Benditt EP, Walsh KA. Amino acid sequence of amyloid-related apoprotein (apoSAAl) from human high-density lipoprotein. Biochemistry 1982;21:3298-3303.
  • Sletten K, Husby G. The complete amino-acid sequence of non-immunoglobulin amyloid fibril protein AS in Rheumatoid arthritis. Eur J Biochem 1974;41:117-125.
  • Syversen PV, Juul J, Marhaug G, Husby G, Sletten K. The primary structure of serum amyloid-A protein in the sheep -- comparison with serum amyloid-A in other species. Scand J Immunol 1994;39:88-94.
  • Lowell CA, Potter DA, Stearman RS, Morrow JE Structure of the murine serum amyloid A gene family. Gene conversion. J Biol Chem 1986;261:8442-8452.
  • Rokita H, Shirahama T, Cohen AS, Meek RL, Benditt EP, Sipe JD. Differential expression of the amyloid SAA gene in liver and peritoneal macrophages of mice undergoing dissimilar inflammatory episodes. J Immunol 1987;139:3849-3853.
  • Benditt EP, Meek RL. Expression of the thud member of the serum amyloid A gene family in mouse adipocytes. J Exp Med 1989;169:1841-1846.
  • Kluve-Beckerman B, Naylor SL, Marshall A, Gardner JC, Shows TB, Benson MD. Localization of human SAA gene(s) to chromosome 11 and detection of DNA polymorphisms. Biochem Biophys Res Comm 1986;137:1196-1204.
  • Taylor BA, Rowe L. Genes for serum amyloid-A proteins map to chromosome -7 in the mouse. Mol Gen Genet 1984;195:491-499.
  • Whitehead AS, Debeer MC, Steel DM, Rits M, Lelias JM, Lane WS, deBeer FC. Identification of novel members of the serum amyloid-A protein superfamily as constitutive apolipoproteins of high density lipoprotein. J Biol Chem 1992;267:3862-3867.
  • Debeer MC, Kindy MS, Lane WS, deBeer FC. Mouse serum amyloid A protein [SAA(S)] structure and expression. J Biol Chem 1994;26 9:4661 H:667.
  • Debeer MC, Yuan T, Kindy MS, Asztalos BF, Roheim PS, deBeer FC. Characterization of constitutive human serum amyloid A protein (SA A (4)) as an apolipoprotein. J Lipid Res 1995;36:526-534.
  • Meek RL., Eriksen N, Benditt ER Murine serum amyloid-A (3) is a high density apolipoprotein and is secreted by macrophages. Proc Natl Acad Sci. USA 1992;89:7949-7952.
  • Kushner I, Rzewnicki DL. The acute phase response: general aspects. In Husby G, ed. Clinical Rheumatology: vol. 8 no. 3, Reactive Amyloidosis and the Acute Phase Response. London: BailliereTindall, 1994;513-530.
  • Tatsuta E, Shirahama T, Sipe ID, Skinner M, Cohen AS. Kinetics of SAP and SAA production by cultured mouse liver cells. Ann NY Acad Sci. 1982;389:467-470.
  • Hoffman JS, Ericsson LH, Eriksen N, Walsh KA, Benditt EP. Murine tissue amyloid protein AA: NH2-terminal sequence identity with only one of two serum amyloid protein (ApoSAA) gene products. J Exp Med 1984;159:641-646.
  • Liepnieks JJ, Kluve-Beckerman B, Benson MD. Characterization of amyloid A protein in human secondary amyloidosis: The predominant deposition of serum amyloid Al. Biochim Biophys Acta 1995;1270:81-86.
  • Whicher JT, Chambers RE, Higginson J, Nashef L, Higgins PG. Acute phase response of serum amyloid A protein and C-reactive protein to the common cold and influenza. J Clin Pathol 1985;38:312.
  • Biran H, Friedman N, Nuemann L, Pras M, Shainkin-Kestenbaum R. Serum amyloid A (SAA) variations in patients with cancer:correlation with disease activity, stage, primary site, and prognosis. J Clin Pathol 1986;39:794-797.
  • Benson MD, Cohen AS. Serum amyloid A protein in amyloidosis, rheumatic and neoplastic diseases. Arthritis Rheum 1979;22:36-42.
  • Janigan DT. Experimental amyloidosis: Studies with a modified casein method, casein hydrolysate and gelatin. Am J Pathol 1965;47:159-169.
  • Bausserman LL, Sadaniantz A, Saritelli AL, Martin VL, Nugent AM, Sady SP, Herbert PN. Time course of serum amyloid-A response in myocardial infarction. Clin Chim Acta 1989;184:297-306.
  • Casl MT, Surina B, Glqjnaric-Spasic I, Pape E, Jagarinec N, Kranjcevic S. Serum amyloid A protein in patients with acute myocardial infarction. Ann Clin Biochem 1995;32:196-200.
  • Clifton PM, Mackinnon AM, Barter PJ. Effects of serum amyloid A protein (SAA) on composition, size, and density of high density lipoproteins in subjects with myocardial infarction. J Lipid Res 1985;26:1389-1398.
  • Morrow JF, Stearman RS, Peltzman CG, Potter DA. Induction of hepatic synthesis of serum amyloid A protein and actin. Proc Natl Acad Sci. USA 1981;78:4718-4722.
  • McAdam KPWJ, EIin RJ, Sipe JD, Wolff SM. Changes in human serum amyloid-A and C-reactive protein after etiocholanolone-induced inflammation. J Clin Invest 1978;61:390-394.
  • Edbrooke MR, Foldi J, Cheshire JK, Li F, Faulkes DJ, Woo P. Constitutive and NFkappa B like proteins in the regulation of the serum amyloid-A gene by interleukin-1. Cytokine 1991;3:380-388.
  • Ray BK, Chatterjee S, Ray A. Mechanism of minimally modified LDL-mediated induction of serum amyloid A gene in monocyte/macrophage cells. DNA Cell Biol 1999;18:65-73.
  • Ray A, Schatten H, Ray BK. Activation of SpI and its functional co-operation with serum amyloid A-activating sequence binding factor in synoviocyte cells trigger synergistic action of interleukin-1 and interleukin-6 in serum amyloid A gene expression. J Biol Chem 1999;274:4300-4308
  • Jiang SL, Lozanski G, Samols D, Kushner I. Induction of human serum amyloid A in Hep 3B cells by IL-6 and IL-I beta involves both transcriptional and post-transcriptional mechanisms. J Immunol 1995;154:825-831.
  • Steel DM, Rogers JT, Debeer MC, deBeer FG, Whitehead AS. Biosynthesis of human acute-phase serum amyloid A-protein (A-SAA) in vitro-the roles of messenger RNA accumulation, poly( A) tail shortening and translational efficiency. Biochem J 1993;291:701-707.
  • Brissette L, Young I, Narindrasorasak S, Kisilevsky R, Deeley R. Differential induction of the serum amyloid-A gene family in response to an inflammatory agent and to amyloid- enhancing factor. J Biol Chem 1989;264:19327-19332.
  • Segrest JP, Pownall HJ, Jackson RL, Glenner GG, Pollock PS. Amyloid A:amphipathic helixes and lipid binding. Biochemistry 1976;15:3187-3191.
  • Benditt EP, Eriksen N. Amyloid protein SAA is associated with high density lipoprotein from human serum. Proc Natl Acad Sci. USA 1977;74:4025-4028.
  • Benditt EP, Eriksen N, Hanson RH. Amyloid protein SAA is an apoprotein of mouse plasma high density lipoprotein. Proc Natl Acad Sci. USA 1979;76:4092-4096.
  • Coetzee GA, Strachan AF, van derWesthuyzen DR, Hoppe HC, Jeenah MS, de Beer FC. Serum amyloid A-containing human high density lipoprotein 3: density, size, and apolipoprotein composition. J Biol Chem 1986;261:9644-9651.
  • Husebekk A, Skogen B, Husby G. Characterization of amyloid proteins AA and SAA as apolipoproteins of high density lipoproteins (HDL). Displacement of SAA from the HDL-SAA complex by apoA-I and apoA-II. Scand J Immunol 1987;25:375-382.
  • MiidaT, Yamada T, Yamadera T, Ozaki K, Inano K, Okada M. Serum amyloid A protein generates pre ß 1 high-density lipoprotein from a-migrating high-density lipoprotein. Biochemistry 1999;38:16958-16962.
  • Fielding CJ, Fielding PE. Molecular physiology of reverse cholesterol transport-review. J Lipid Res 1995;36:211-228.
  • Cabana VG, Reardon CA, Wei B, Lukens JR, Getz GS. SAA-only HDL formed during the acute phase response in apoA-I+/+ andapoA-I-/- mice. J Lipid Res 1999:40:1090-1103.
  • Tape C, Kisilevsky R. ApoIipoprotein-A-I and apolipoprotein SAA half-lives during acute inflammation and amyloidogenesis. Biochim Biophys Acta 1990;1043:295-300.
  • van der Westhuyzen DR, Coetzee GA, de Beer FC. Serum amyloid A protein in plasma: characteristics of acute phase HDL. In Marrink J, van Rijswijk MH, eds. Amyloidosis. Dordrecht: Martinus Nijhoff, 1986;115-125.
  • Turnell W, Sarra R, Glover ID, Baum JO, Caspi D, Baltz ML, Pepys MB. Secondary structure prediction of human SA Al presumptive identification of calcium and lipid binding sites. Mol Biol Med 1986;3:387:408.
  • Glenner GG. Amyloid deposits and amyloidosis. The B-fibrilloses. Part I and II. N Engl J Med 1980,302:1283-1292.
  • Meeker AK, Sack GH. A fusion protein between serum amyloid A and staphylococcal nuclease-synthesis, purification, and structural studies. Protein-Struct Funct Genet 1998;30:381-387.
  • Hoffman JS, Benditt EP. Secretion of serum amyloid protein and assembly of serum amyloid protein-rich high density lipoprotein in primary mouse hepatocyte culture. J Biol Chem 1982;257:10518-10522.
  • Patel H, Bramall J, Waters H, Debeer MC, Woo P. Expression of recombinant human serum amyloid A in mammalian cells and demonstration of the region necessary for high-density lipoprotein binding and amyloid fibril formation by site-directed mutagenesis. Biochem J 1996;318:1041-1049.
  • Malle E, Munscher G, Muller T, Vermeer H, Ibovnik A. Quantification and mapping of antigenic determinants of serum amyloid A (SAA) protein utilizingsequence-specific immune-globulins and Eu3+ as a specific probe for time-resolved fluorometric immunoassay. J Immunol Meth 1995;182:131-144.
  • Malle E, Herz R, Artl A, Ibovnik A, Andreae F, Sattler W. Mapping of antigenic determinants of purified, lipid-free human serum amyloid A proteins. Scan J Immunol 1998;48:557-561.
  • Liang JS, Schreiber BM, Salmona M, Phillip G, Gonnerman WA, deBeer FC, Sipe JD. Amino terminal region of acute phase, but not constitutive, serum amyloid A (apoSAA) specifically binds and transports cholesterol into aortic smooth muscle and HepG2 cells. J Lipid Res 1996;37:2109-2116.
  • Preciado-Patt L, Levartowsky D, Prass M, Hershkoviz R, Lider O, Fridkin M. Inhibition of cell adhesion to glycoproteins of the extracellular matrix by peptides corresponding to serum amyloid A--toward understanding the physiological role of an enigmatic protein. Eur J Biochem 1994;223:35-42.
  • Syversen PV, Saeter U, Cunhar-Ibeiro L, Orvim U, Sletten K, Husby G, Sakariassen KS. The effect of serum amyloid protein A fragment-SAA(25-76) on blood platelet aggregation.Thromb Res 1994;76:299-305.
  • Zimlichman S, Danon A, Nathan I, Mozes G, Shainkin-Kestenbaum R. Serum amyloid-A, an acute phase protein, inhibits platelet activation. J Lab Clin Med 1990;116:180-186.
  • Malle E, Bollmann A, Steinmetz A, Gemsa D, Leis HJ, Sattler W. Serum amyloid A (SAA) protein enhances formation of cyclooxygenase metabolites of activated human monocytes. FEES Lett 1997;419:215-219.
  • Preciado-Patt L, Pras M, Fridkin M. Binding of human serum amyloid A (hSAA) and its high-density lipoprotein(3) complex [hSAA-HDL(3)] to human neutrophils - Possible implication to the function of a protein of an unknown physiological role. IntJ Pept Protein Res 1996;48:503-513.
  • Ancsin JB, Kisilevsky R. The heparin/heparan sulfate-binding site on apo-serum amyloid A: implications for the therapeutic intervention of amyloidosis. J Biol Chem 1999;274:7172-7181.
  • Rocken C, Kisilevsky R. Binding and endocytosis of high density lipoprotein from healthy (HDL) and inflammed (HDLsaa) donors by murine macrophages in-vitro. A light and electronmicroscopic investigation. Amyloid 1997;4:259-273.
  • Benson MD, Aldo-Benson MA. SAA suppression of immune response in vitro: evidence for an effect onTcell-macrophage interaction. J immunol 1982;128:2390-2392.
  • Badolato R, Wang JM, Murphy WJ, Lloyd AR, Michiel DF, Bausserman LL, Kelvin DJ, Oppenheim JJ. Serum amyloid A is a chemoattractant: induction of migration, adhesion, and tissue infiltration of monocytes and polymorphonuclear leukocytes. J Exp Med 1994;180:203-209.
  • Xu LL, Badolato R, Murphy WJ, Longo DL, Anver M, Hale S, Oppenheim JJ, Wang JM. A novel biologic function of serum amyloid A-induction of T lymphocyte migration and adhesion. J immunol 1995;155:1184-1190.
  • Hershkoviz R, Preciado-Patt L, Lider O, Fridkin M, Dastych J, Metcalfe DD, Mekori YA. Extracellular matrix-anchored serum amyloid A preferentially induces mast cell adhesion. Am J Physiol Cell Physaol 1997; 42:C179-C187.
  • Preciado-Patt L, Hershkoviz R, Fridkin M, Lider O. Serum amyloid A binds specific extracellular matrix glycoproteins and induces the adhesion of resting CD4(+) T cells. J immunol 1996;156:1189-1195.
  • Peristeris P, Caspar A, Gros P, Laurent P, Bernon H, Bienvenu J. Effects of serum amyloid-A protein on lymphocytes, HeLa, and Mrc5 cells in culture. Biochem Cell Biol 1989;67:365-370.
  • Linke RP, Bock V, Valet G, Rothe G. Inhibition of the oxidative burst response of N-formyl peptide-stimulated neutrophils by serum amyloid-A protein. Biochem. Biophys Res Commun 1991;176:1100-1105.
  • Sack GH, Talbot CC. The human serum amyloid-A (SAA)-encoding gene Gsaal -- nucleotide sequence and possible autocrine-collagenase-inducer function. Gene 1989;84:509-515.
  • Mitchell TI, Coon CI, Brinckerhoff CE. Serum amyloid-A (SAA3) produced by rabbit synovial fibroblasts treated with phorbol esters or interleukin-1 induces synthesis of collagenase and is neutralized with specific antiserum. J Clin invest 1991;87:1177-1185.
  • Pruzanski W, deBeer FC, Debeer MC, Stefanski E, Vadas P. Serum amyloid A protein enhances the activity of secretory non-pancreatic phospholipase A(2). Biochem J 1995;309:461-464.
  • Steinmetz A, Hocke G, Saile R, Puchois P, Fruchart JC. Influence of serum amyloidA on cholesterol esterification in human plasma. Biochim Biophys Acta 1989;1006:173-178.
  • Mindham MA, Mayes PA, Miller NE. Reverse cholesterol transport in the isolated perfused rat spleen. Biochem J 1990,268:499- 505.
  • Mindham MA, Mayes PA. Reverse Cholesterol transport in the rat-studies using the isolated perfused spleen in conjunction with the perfused liver. Biochem J 1991;279:503-508.
  • Kisilevsky R. Serum amyloid-A (SAA), a protein without a function - some suggestions with reference to cholesterol metabolism. Med Hypotheses 1991;35:337-341.
  • Kisilevsky R, Lindhorst E, Ancsin JB, Young D, Bagshaw W. Acute phase serum amyloid A (SAA) and cholesterol transport during acute inflammation: a hypothesis. Amyloid 1996;3:252-260.
  • Fantone JC, Ward PA. Inflammation. In Rubin E, Farber J, eds. Pathology, 2 ed. Philadelphia: Lippincott, 1994;32-67.
  • MacchiaT, Mancinelli R, Barbini DA,Taggi F, Avico U, Cantafora A. Determination of membrane cholesterol in normal and pathological red blood cells. Clin Chim Acta 1991;199:59-67.
  • Cooper RA. Influence of increased membrane cholesterol on membrane fluidity and cell function in human red blood cells. J Supramol Struct 1978;8:413-430.
  • Kumon Y, Nakauchi Y, Kidawara K, Fukushima M, Kobayashi S, Ikeda Y, Suehiro T, Hashimoto K, Sipe JD. A longitudinal analysis of alteration in lecithin-cholesterol acyltransferase and paraoxonase activities following laparoscopic cholecystectomy relative to other parameters of HDL function and the acute phase response. Scand J Immunol 1998;48:419-t24.
  • Su SB, Gong WH, Gao JL, Shen WP, Murphy PM, Oppenheim JJ, Wang JM. A seventransmembrane, G protein-coupled receptor, FPRLl, mediates the chemotactic activity of serum amyloid A for human phagocytic cells. J Exp Med 1999;189:395-402.
  • Artl A, Marsche G, Lestavel S, Sattler W, Malle E. Role of serum amyloid A during metabolism of acute-phase HDL by macrophages. Arterio Thromb Vase Biol 200020:763-772.
  • Chronopoulos S, Chan SL, Ratcliffe MJH, Ali-Khan Z. Colocalization of ubiquitin and serum amyloid A and ubiquitin-bound AA in the endosomes-lysosomes : a double immunogold electron microscopic study. Amyloid 1995;2:191-194.
  • Liang JS, Sipe JD. Recombinant human serum amyloid A [apoSAA(p)] binds cholesterol and modulates cholesterol flux. J Lipid Res 1995;36:37-46.
  • Kisilevsky R, Subrahmanyan L. Serum amyloid A influences the efflux of cholesterol from macrophages. In Kisilevsky R, Benson MD, Frangione B, Gauldie J, Muekle TJ, \bung ID, eds. Amyloid and Amyloidosis 1993. Park Ridge, NJ: Parthenon Publishing Group, 1994;115-118.
  • Hayat S, Raynes JG. Serum amyloid A has little effect on high density lipoprotein (HDL) binding to U937 monocytes but may influence HDL mediated cholesterol transfer. Biochem Soc Trans 1997;25:S348-S348.
  • Gonnerman WA, Lim M, Sipe JD, Hayes KC, Cathcart ES. The acute phase response in Syrian hamsters elevates apolipoprotein serum amyloid A (apoSAA) and disrupts lipoprotein metabolism. Amyloid 1996;3:261-269.
  • Meek RL, Urieli-Shoval S, Benditt EP. Expression of apolipoprotein serum amyloidA messenger RNA in human atherosclerotic lesions and cultured vascular cells-implications for serum amyloid-A function. Proc Natl Acad Sci. USA 1994;91:3186-3190.
  • Khovidhunkit W, Memon RA, Feingold KR, Grunfeld C. Infection and inflammation-induced proatherogenic changes of lipoproteins. J Infect Dis 2000 suppl 3:S462-S472.
  • Van Lenten BJ, Kama SY, de Beer FC, Stafforini DM, Mcintyre TM, Prescott SM, La du BN, Fogelman AM, Navab M. Anti-inflammatory HDL becomes proinflammatory during the acute phase response-loss of protective effect of HDL against LDL oxidation in aortic wall cell cocultures. J Clin Invest 1995;96:2758-2767.
  • Munro JM, Cotran RS. The pathogenesis of atherosclerosis: atherogenesis and inflammation. Lab Invest 1988;58:249-261.
  • Rotti N, Giansante C, Ponte E, Delbello C, Calabrese S, Zacchi T, Dobrina A, Guarnieri G. Atherosclerosis and inflammation. Patterns of cytokine regulation in patients with peripheral arterial disease. Atherosclerosis 1999;145:51-60.
  • Morrow DA, Ridker PM. C-reactive protein, inflammation, and coronary risk. Med Clin N Am2000;84:149.
  • Ridker PM, Rifai N, Pfeffer MA, Sacks FM, Moye LA, Goldman S, Flaker GC, Braunwald E. Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Circulation 1998;98:839-844.
  • Stefanidis C, Diamantopoulos L, Dernellis J, Economou E, Tsiamis E, Tbutouzas K, Vlachopoulos C, Toutouzas P. Heat production of atherosclerotic plaques and inflammation assessed by the acute phase proteins in acute coronary syndromes. J Mol Cell Cardiol 2000;32:43-52.
  • Moore S. Vascular system. In Damjanov I, Linder J, eds. Anderson's Pathology, 10th ed. St. Louis: Mosby, 1996;1397-1445.
  • Oram JF. Does serum amyloid A mobilize cholesterol from macrophages during inflammation. Amyloid 1996;3:290-293.
  • Schreiber BM, Veverbrants M, Fine RE, Blusztajn JK, Salmona M, Patel A, Sipe JD. Apolipoprotein serum amyloid A down-regulates smooth-muscle cell lipid biosynthesis. Biochem J 1999;344:7-13.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.